Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Vukelic, Z; Metelmann, W; Muthing, J; Kos, M; Peter-Katalinic, J
   Anencephaly: Structural characterization of gangliosides in defined brain regions
   BIOLOGICAL CHEMISTRY
   
   Z. Vukelic et al., "Anencephaly: Structural characterization of gangliosides in defined brain regions", BIOL CHEM, 382(2), 2001, pp. 259-274
2. Teixeira, CA; Sena-Esteves, M; Lopes, L; Miranda, MCS; Ribeiro, MG
   Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant
   HUMAN GENE THERAPY
   
   C.A. Teixeira et al., "Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant", HUM GENE TH, 12(14), 2001, pp. 1771-1783
3. Schuette, CG; Pierstorff, B; Huettler, S; Sandhoff, K
   Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis
   GLYCOBIOLOGY
   
   C.G. Schuette et al., "Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis", GLYCOBIOLOG, 11(6), 2001, pp. 81R-90R
4. Li, JG; Rancour, DM; Allende, ML; Worth, CA; Darling, DS; Gilbert, JB; Menon, AK; Young, WW
   The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding
   GLYCOBIOLOGY
   
   J.G. Li et al., "The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding", GLYCOBIOLOG, 11(3), 2001, pp. 217-229
5. Kirkwood, JM; Ibrahim, JG; Sosman, JA; Sondak, VK; Agarwala, SS; Ernstoff, MS; Rao, U
   High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.M. Kirkwood et al., "High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801", J CL ONCOL, 19(9), 2001, pp. 2370-2380
6. Taniguchi, M; Shinoda, Y; Ninomiya, H; Vanier, MT; Ohno, K
   Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain
   BRAIN & DEVELOPMENT
   
   M. Taniguchi et al., "Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain", BRAIN DEVEL, 23(6), 2001, pp. 414-421
7. Usuki, S; Ren, J; Utsunomiya, I; Cashman, NR; Inokuchi, J; Miyatake, T
   GM2 ganglioside regulates the function of ciliary neurotrophic factor receptor in murine immortalized motor neuron-like cells (NSC-34)
   NEUROCHEMICAL RESEARCH
   
   S. Usuki et al., "GM2 ganglioside regulates the function of ciliary neurotrophic factor receptor in murine immortalized motor neuron-like cells (NSC-34)", NEUROCHEM R, 26(4), 2001, pp. 375-382
8. Stern, CA; Tiemeyer, M
   A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons
   JOURNAL OF NEUROSCIENCE
   
   C.A. Stern e M. Tiemeyer, "A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons", J NEUROSC, 21(5), 2001, pp. 1434-1443
9. Sardesai, N; Rajyashri, KR; Behura, SK; Nair, S; Mohan, M
   Genetic, physiological and molecular interactions of rice and its major dipteran pest, gall midge
   PLANT CELL TISSUE AND ORGAN CULTURE
   
   N. Sardesai et al., "Genetic, physiological and molecular interactions of rice and its major dipteran pest, gall midge", PL CELL TIS, 64(2-3), 2001, pp. 115-131
10. Kaida, K; Kusunoki, S; Kamakura, K; Motoyoshi, K; Kanazawa, I
    Guillain-Barre syndrome with IgM antibody to the ganglioside GalNAc-GDla
    JOURNAL OF NEUROIMMUNOLOGY
    
    K. Kaida et al., "Guillain-Barre syndrome with IgM antibody to the ganglioside GalNAc-GDla", J NEUROIMM, 113(2), 2001, pp. 260-267
11. Wu, GS; Lu, ZH; Xie, X; Ledeen, R
    Comparison of ganglioside profiles in nuclei and whole cells of NG108-15 and NG-CR72 lines: changes in response to different neuritogenic stimuli
    DEVELOPMENTAL BRAIN RESEARCH
    
    G.S. Wu et al., "Comparison of ganglioside profiles in nuclei and whole cells of NG108-15 and NG-CR72 lines: changes in response to different neuritogenic stimuli", DEV BRAIN R, 126(2), 2001, pp. 183-190
12. Beccari, T; Balducci, C; Aisa, MC; Della Fazia, MA; Servillo, G; Orlacchio, A
    Promoter characterization and expression of the gene coding for the human GM2 activator protein
    BIOSCIENCE REPORTS
    
    T. Beccari et al., "Promoter characterization and expression of the gene coding for the human GM2 activator protein", BIOSCI REP, 21(1), 2001, pp. 55-62
13. Salman, MS; Clarke, JTR; Midroni, G; Waxman, MB
    Peripheral and autonomic nervous system involvement in chronic GM2-gangliosidosis
    JOURNAL OF INHERITED METABOLIC DISEASE
    
    M.S. Salman et al., "Peripheral and autonomic nervous system involvement in chronic GM2-gangliosidosis", J INH MET D, 24(1), 2001, pp. 65-71
14. Brady, RO
    Tay-Sachs disease: The search for the enzymatic defect
    TAY-SACHS DISEASE
    
    R.O. Brady, "Tay-Sachs disease: The search for the enzymatic defect", ADV GENETIC, 44, 2001, pp. 51-60
15. Sandhoff, K
    The G(M2)-gangliosidoses and the elucidation of the beta-hexosaminidase system
    TAY-SACHS DISEASE
    
    K. Sandhoff, "The G(M2)-gangliosidoses and the elucidation of the beta-hexosaminidase system", ADV GENETIC, 44, 2001, pp. 67-91
16. Kolodny, EH
    Molecular genetics of the beta-hexosaminidase isoenzymes: An introduction
    TAY-SACHS DISEASE
    
    E.H. Kolodny, "Molecular genetics of the beta-hexosaminidase isoenzymes: An introduction", ADV GENETIC, 44, 2001, pp. 101-126
17. Mahuran, DJ; Gravel, RA
    The beta-hexosaminidase story in Toronto: From enzyme structure to gene mutation
    TAY-SACHS DISEASE
    
    D.J. Mahuran e R.A. Gravel, "The beta-hexosaminidase story in Toronto: From enzyme structure to gene mutation", ADV GENETIC, 44, 2001, pp. 145-163
18. Neufeld, EF; d'Azzo, A
    Biosynthesis of normal and mutant beta-hexosaminidases
    TAY-SACHS DISEASE
    
    E.F. Neufeld e A. d'Azzo, "Biosynthesis of normal and mutant beta-hexosaminidases", ADV GENETIC, 44, 2001, pp. 165-171
19. Suzuki, K
    Recognition and delineation of beta-hexosaminidase alpha-chain variants: Ahistorical and personal perspective
    TAY-SACHS DISEASE
    
    K. Suzuki, "Recognition and delineation of beta-hexosaminidase alpha-chain variants: Ahistorical and personal perspective", ADV GENETIC, 44, 2001, pp. 173-184
20. Navon, R
    Late-onset G(M2) gangliosidosis and other hexosaminidase mutations among Jews
    TAY-SACHS DISEASE
    
    R. Navon, "Late-onset G(M2) gangliosidosis and other hexosaminidase mutations among Jews", ADV GENETIC, 44, 2001, pp. 185-197
21. Triggs-Raine, B; Mahuran, DJ; Gravel, RA
    Naturally occurring mutations in G(M2) gangliosidosis: A compendium
    TAY-SACHS DISEASE
    
    B. Triggs-Raine et al., "Naturally occurring mutations in G(M2) gangliosidosis: A compendium", ADV GENETIC, 44, 2001, pp. 199-224
22. Katiyar, SK; Tan, Y; Huang, B; Chandel, G; Xu, Y; Zhang, Y; Xie, Z; Bennett, J
    Molecular mapping of gene Gm-6(t) which confers resistance against four biotypes of Asian rice gall midge in China
    THEORETICAL AND APPLIED GENETICS
    
    S.K. Katiyar et al., "Molecular mapping of gene Gm-6(t) which confers resistance against four biotypes of Asian rice gall midge in China", THEOR A GEN, 103(6-7), 2001, pp. 953-961
23. Gilewski, T; Ragupathi, G; Bhuta, S; Williams, LJ; Musselli, C; Zhang, XF; Bencsath, KP; Panageas, KS; Chin, J; Hudis, CA; Norton, L; Houghton, AN; Livingston, PO; Danishefsky, SJ
    Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    T. Gilewski et al., "Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial", P NAS US, 98(6), 2001, pp. 3270-3275
24. Giraudo, CG; Daniotti, JL; Maccioni, HJF
    Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C.G. Giraudo et al., "Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus", P NAS US, 98(4), 2001, pp. 1625-1630
25. Zervas, M; Dobrenis, K; Walkley, SU
    Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    M. Zervas et al., "Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations", J NE EXP NE, 60(1), 2001, pp. 49-64
26. Yoshida, S; Fukumoto, S; Kawaguchi, H; Sato, S; Ueda, R; Furukawa, K
    Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis
    CANCER RESEARCH
    
    S. Yoshida et al., "Ganglioside G(D2) in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis", CANCER RES, 61(10), 2001, pp. 4244-4252
27. Sottocornola, E; Colombo, I; Berra, B
    Stable transfection of human beta-1,4N-acetylgalactosaminyltransferase andalpha-2,8-sialyltransferase cDNAs in C6 rat glioma cells induces modifications in ganglioside metabolism
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
    
    E. Sottocornola et al., "Stable transfection of human beta-1,4N-acetylgalactosaminyltransferase andalpha-2,8-sialyltransferase cDNAs in C6 rat glioma cells induces modifications in ganglioside metabolism", EUR J LIPID, 102(11), 2000, pp. 673-679
28. Schepers, U; Lemm, T; Herzog, V; Sandhoff, K
    Characterization of regulatory elements in the 5 '-flanking region of the GM2 activator gene
    BIOLOGICAL CHEMISTRY
    
    U. Schepers et al., "Characterization of regulatory elements in the 5 '-flanking region of the GM2 activator gene", BIOL CHEM, 381(7), 2000, pp. 531-544
29. Liscum, L
    Niemann-Pick type C mutations cause lipid traffic jam
    TRAFFIC
    
    L. Liscum, "Niemann-Pick type C mutations cause lipid traffic jam", TRAFFIC, 1(3), 2000, pp. 218-225
30. 
    The anti-idiotypic antibody 4B5 (mimicking ganglioside GD2) for diagnosis and therapy of cancer
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    EXPERT OP T, 10(2), 2000, pp. 255-257
31. Cordeiro, P; Hechtman, P; Kaplan, F
    The G(M2) gangliosidoses databases: Allelic variation at the HEXA, HEKB, and GM2A gene loci
    GENETICS IN MEDICINE
    
    P. Cordeiro et al., "The G(M2) gangliosidoses databases: Allelic variation at the HEXA, HEKB, and GM2A gene loci", GENET MED, 2(6), 2000, pp. 319-327
32. Gilewski, T; Adluri, S; Ragupathi, G; Zhang, SL; Yao, TJ; Panageas, K; Moynahan, M; Houghton, A; Norton, L; Livingston, PO
    Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21
    CLINICAL CANCER RESEARCH
    
    T. Gilewski et al., "Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21", CLIN CANC R, 6(5), 2000, pp. 1693-1701
33. Chapman, PB; Morrisey, D; Panageas, KS; Williams, L; Lewis, JJ; Israel, RJ; Hamilton, WB; Livingston, PO
    Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin
    CLINICAL CANCER RESEARCH
    
    P.B. Chapman et al., "Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin", CLIN CANC R, 6(12), 2000, pp. 4658-4662
34. Walkley, SU; Zervas, M; Wiseman, S
    Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons
    CEREBRAL CORTEX
    
    S.U. Walkley et al., "Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons", CEREB CORT, 10(10), 2000, pp. 1028-1037
35. Tsurifune, T; Ito, T; Li, XJ; Yamashiro, S; Okada, M; Kanematsu, T; Shiku, H; Furukawa, K
    Alteration of tumor phenotypes of B16 melanoma after genetic remodeling ofthe ganglioside profile
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    T. Tsurifune et al., "Alteration of tumor phenotypes of B16 melanoma after genetic remodeling ofthe ganglioside profile", INT J ONCOL, 17(1), 2000, pp. 159-165
36. Hanibuchi, M; Nishioka, Y; Yanagawa, H; Yano, S; Parajuli, P; Bando, M; Sone, S
    Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity
    ONCOLOGY RESEARCH
    
    M. Hanibuchi et al., "Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity", ONCOL RES, 12(4), 2000, pp. 173-179
37. Liu, YJ; Wu, YP; Wada, R; Neufeld, EB; Mullin, KA; Howard, AC; Pentchev, PG; Vanier, MT; Suzuki, K; Proia, RL
    Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse
    HUMAN MOLECULAR GENETICS
    
    Y.J. Liu et al., "Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse", HUM MOL GEN, 9(7), 2000, pp. 1087-1092
38. Tifft, CJ; Proia, RL
    Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases
    GLYCOBIOLOGY
    
    C.J. Tifft e R.L. Proia, "Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases", GLYCOBIOLOG, 10(12), 2000, pp. 1249-1258
39. Allende, ML; Li, JH; Darling, DS; Worth, CA; Young, WW
    Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion
    GLYCOBIOLOGY
    
    M.L. Allende et al., "Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion", GLYCOBIOLOG, 10(10), 2000, pp. 1025-1032
40. O'Hanlon, GM; Veitch, J; Gallardo, E; Illa, I; Chancellor, AM; Willison, HJ
    Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: Clinical and immunopathological studies
    AUTOIMMUNITY
    
    G.M. O'Hanlon et al., "Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: Clinical and immunopathological studies", AUTOIMMUN, 32(2), 2000, pp. 133-144
41. Lake, DF; Huynh, WC; Hersh, EM
    Natural and induced human antibody response to cancer
    CANCER INVESTIGATION
    
    D.F. Lake et al., "Natural and induced human antibody response to cancer", CANCER INV, 18(5), 2000, pp. 480-489
42. Pitts, JM; Maloney, ME
    Therapeutic advances in melanoma
    DERMATOLOGIC CLINICS
    
    J.M. Pitts e M.E. Maloney, "Therapeutic advances in melanoma", DERM CLIN, 18(1), 2000, pp. 157
43. Foon, KA; Lutzky, J; Baral, RN; Yannelli, JR; Hutchins, L; Teitelbaum, A; Kashala, OL; Das, R; Garrison, J; Reisfeld, RA; Bhattacharya-Chatterjee, M
    Clinical and immune responses in advanced melanoma patients immunized withan anti-idiotype antibody mimicking disialoganglioside GD2
    JOURNAL OF CLINICAL ONCOLOGY
    
    K.A. Foon et al., "Clinical and immune responses in advanced melanoma patients immunized withan anti-idiotype antibody mimicking disialoganglioside GD2", J CL ONCOL, 18(2), 2000, pp. 376-384
44. Wu, XS; Okada, N; Goto, M; Iwamoto, A; Okada, H
    The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients
    MICROBIOLOGY AND IMMUNOLOGY
    
    X.S. Wu et al., "The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients", MICROB IMMU, 44(5), 2000, pp. 405-410
45. Hanai, N; Nakamura, K; Shitara, K
    Recombinant antibodies against ganglioside expressed on tumor cells
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    N. Hanai et al., "Recombinant antibodies against ganglioside expressed on tumor cells", CANC CHEMOT, 46, 2000, pp. S13-S17
46. Perico, ME; Mezzanzanica, D; Luison, E; Alberti, P; Panza, L; Russo, G; Canevari, S
    Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    M.E. Perico et al., "Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1", CANCER IMMU, 49(6), 2000, pp. 296-304
47. Zelnik, N; Khazanov, V; Sheinkman, A; Karpati, AM; Peleg, L
    Clinical manifestations of psychiatric patients who are carriers of Tay-Sachs disease - Possible role of psychotropic drugs
    NEUROPSYCHOBIOLOGY
    
    N. Zelnik et al., "Clinical manifestations of psychiatric patients who are carriers of Tay-Sachs disease - Possible role of psychotropic drugs", NEUROPSYCHB, 41(3), 2000, pp. 127-131
48. Livingston, PO; Ragupathi, G; Musselli, C
    Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues
    JOURNAL OF CLINICAL IMMUNOLOGY
    
    P.O. Livingston et al., "Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues", J CLIN IMM, 20(2), 2000, pp. 85-93
49. Brezicka, T; Bergman, B; Olling, S; Fredman, P
    Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues
    LUNG CANCER
    
    T. Brezicka et al., "Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues", LUNG CANC, 28(1), 2000, pp. 29-36
50. Nakamura, K; Tanaka, Y; Fujino, I; Hirayama, N; Shitara, K; Hanai, N
    Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody
    MOLECULAR IMMUNOLOGY
    
    K. Nakamura et al., "Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody", MOL IMMUNOL, 37(17), 2000, pp. 1035-1046
51. Bierfreund, U; Kolter, T; Sandhoff, K
    Sphingolipid hydrolases and activator proteins
    SPHINGOLIPID METABOLISM AND CELL SIGNALING, PT A
    
    U. Bierfreund et al., "Sphingolipid hydrolases and activator proteins", METH ENZYM, 311, 2000, pp. 255-276
52. Ito, M; Kita, K; Kurita, T; Sueyoshi, N; Izu, H
    Enzymatic N-deacylation of sphingolipids
    SPHINGOLIPID METABOLISM AND CELL SIGNALING, PT A
    
    M. Ito et al., "Enzymatic N-deacylation of sphingolipids", METH ENZYM, 311, 2000, pp. 297-303
53. Ang, CW; Jacobs, BC; Brandenburg, AH; Laman, JD; van der Meche, FGA; Osterhaus, ADME; van Doorn, PA
    Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome
    NEUROLOGY
    
    C.W. Ang et al., "Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome", NEUROLOGY, 54(7), 2000, pp. 1453-1458
54. Wang, ZG; Williams, LJ; Zhang, XF; Zatorski, A; Kudryashov, V; Ragupathi, G; Spassova, M; Bornmann, W; Slovin, SF; Scher, HI; Livingston, PO; Lloyd, KO; Danishefsky, SJ
    Polyclonal antibodies from patients immunized with a globe H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    Z.G. Wang et al., "Polyclonal antibodies from patients immunized with a globe H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens", P NAS US, 97(6), 2000, pp. 2719-2724
55. Behura, SK; Nair, S; Sahu, SC; Mohan, M
    An AFLP marker that differentiates biotypes of the Asian rice gall midge (Orseolia oryzae, Wood-Mason) is sex-linked and also linked to avirulence
    MOLECULAR AND GENERAL GENETICS
    
    S.K. Behura et al., "An AFLP marker that differentiates biotypes of the Asian rice gall midge (Orseolia oryzae, Wood-Mason) is sex-linked and also linked to avirulence", MOL G GENET, 263(2), 2000, pp. 328-334
56. Lunn, MPT; Johnson, LA; Fromholt, SE; Itonori, S; Huang, J; Vyas, AA; Hildreth, JEK; Griffin, JW; Schnaar, RL; Sheikh, KA
    High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization
    JOURNAL OF NEUROCHEMISTRY
    
    M.P.T. Lunn et al., "High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization", J NEUROCHEM, 75(1), 2000, pp. 404-412
57. Wright, CS; Li, SC; Rastinejad, F
    Crystal structure of human GM2-activator protein with a novel beta-cup topology
    JOURNAL OF MOLECULAR BIOLOGY
    
    C.S. Wright et al., "Crystal structure of human GM2-activator protein with a novel beta-cup topology", J MOL BIOL, 304(3), 2000, pp. 411-422
58. Liu, YS; Schweitzer, L; Renehan, WE
    Development of salt-responsive neurons in the nucleus of the solitary tract
    JOURNAL OF COMPARATIVE NEUROLOGY
    
    Y.S. Liu et al., "Development of salt-responsive neurons in the nucleus of the solitary tract", J COMP NEUR, 425(2), 2000, pp. 219-232
59. Hou, YM; Vocadlo, D; Withers, S; Mahuran, D
    Role of beta Arg(211) in the active site of human beta-hexosaminidase B
    BIOCHEMISTRY
    
    Y.M. Hou et al., "Role of beta Arg(211) in the active site of human beta-hexosaminidase B", BIOCHEM, 39(20), 2000, pp. 6219-6227
60. Walkley, SU; Zervas, M; Siegel, DA; Dobrenis, K
    Gangliosides as modulators of dendritogenesis in storage disease-affected and normal pyramidal neurons
    DEVELOPMENTAL NEUROPSYCHOLOGY
    
    S.U. Walkley et al., "Gangliosides as modulators of dendritogenesis in storage disease-affected and normal pyramidal neurons", DEV NEUROPS, 16(3), 1999, pp. 361-364
61. Kolter, T; Sandhoff, K
    Sphingolipids - Their metabolic pathways and the pathobiochemistry of neurodegenerative diseases
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    T. Kolter e K. Sandhoff, "Sphingolipids - Their metabolic pathways and the pathobiochemistry of neurodegenerative diseases", ANGEW CHEM, 38(11), 1999, pp. 1532-1568
62. Cox, J; Coulter, A
    Prospects for the development of new vaccine adjuvants
    BIODRUGS
    
    J. Cox e A. Coulter, "Prospects for the development of new vaccine adjuvants", BIODRUGS, 12(6), 1999, pp. 439-453
63. Dickler, MN; Ragupathi, G; Liu, NX; Musselli, C; Martino, DJ; Miller, VA; Kris, MG; Brezicka, FT; Livingston, PO; Grant, SC
    Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer
    CLINICAL CANCER RESEARCH
    
    M.N. Dickler et al., "Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer", CLIN CANC R, 5(10), 1999, pp. 2773-2779
64. Trifiletti, RR; Packard, AM
    Metabolic disorders presenting with behavioral symptoms in the school-agedchild
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    
    R.R. Trifiletti e A.M. Packard, "Metabolic disorders presenting with behavioral symptoms in the school-agedchild", CH ADOLESC, 8(4), 1999, pp. 791
65. Mundel, TM; Heid, HW; Mahuran, DJ; Kriz, W; Mundel, P
    Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    T.M. Mundel et al., "Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells", J AM S NEPH, 10(3), 1999, pp. 435-443
66. Behura, SK; Sahu, SC; Rajamani, S; Devi, A; Mago, R; Nair, S; Mohan, M
    Differentiation of Asian rice gall midge, Orseolia oryzae (Wood-Mason), biotypes by sequence characterized amplified regions (SCARs)
    INSECT MOLECULAR BIOLOGY
    
    S.K. Behura et al., "Differentiation of Asian rice gall midge, Orseolia oryzae (Wood-Mason), biotypes by sequence characterized amplified regions (SCARs)", INSEC MOL B, 8(3), 1999, pp. 391-397
67. Young, WW; Allende, ML; Jaskiewicz, E
    Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: thelocation of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA
    GLYCOBIOLOGY
    
    W.W. Young et al., "Reevaluating the effect of Brefeldin A (BFA) on ganglioside synthesis: thelocation of GM2 synthase cannot be deduced from the inhibition of GM2 synthesis by BFA", GLYCOBIOLOG, 9(7), 1999, pp. 689-695
68. Mizutani, K; Oka, N; Akiguchi, I; Satoi, H; Kawasaki, T; Kaji, R; Kimura, J
    Enhancement of TNF-alpha production by ganglioside GM2 in human mononuclear cell culture
    NEUROREPORT
    
    K. Mizutani et al., "Enhancement of TNF-alpha production by ganglioside GM2 in human mononuclear cell culture", NEUROREPORT, 10(4), 1999, pp. 703-706
69. Dullenkopf, W; Ritter, G; Fortunato, SR; Old, LJ; Schmidt, RR
    Synthesis of a structurally defined antigen - Immunostimulant combination for use in cancer vaccines
    CHEMISTRY-A EUROPEAN JOURNAL
    
    W. Dullenkopf et al., "Synthesis of a structurally defined antigen - Immunostimulant combination for use in cancer vaccines", CHEM-EUR J, 5(8), 1999, pp. 2432-2438
70. Mahuran, DJ
    Biochemical consequences of mutations causing the GM2 gangliosidoses
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    
    D.J. Mahuran, "Biochemical consequences of mutations causing the GM2 gangliosidoses", BBA-MOL BAS, 1455(2-3), 1999, pp. 105-138
71. Okada, N; Okada, H
    Human IgM antibody therapy for HIV-1 infection
    MICROBIOLOGY AND IMMUNOLOGY
    
    N. Okada e H. Okada, "Human IgM antibody therapy for HIV-1 infection", MICROB IMMU, 43(8), 1999, pp. 729-736
72. Raghavan, S; Leshinsky, E; Kolodny, EH
    G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts
    NEUROCHEMICAL RESEARCH
    
    S. Raghavan et al., "G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts", NEUROCHEM R, 24(4), 1999, pp. 475-479
73. Usuki, S; Cashman, NR; Miyatake, T
    GM2 promotes ciliary neurotrophic factor-dependent rescue of immortalized motor neuron-like cell (NSC-34)
    NEUROCHEMICAL RESEARCH
    
    S. Usuki et al., "GM2 promotes ciliary neurotrophic factor-dependent rescue of immortalized motor neuron-like cell (NSC-34)", NEUROCHEM R, 24(2), 1999, pp. 281-286
74. Bierfreund, U; Lemm, T; Hoffmann, A; Uhlhorn-Dierks, G; Childs, RA; Yuen, CT; Feizi, T; Sandhoff, K
    Recombinant GM2-activator protein stimulates in vivo degradation of GA2 inGM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay
    NEUROCHEMICAL RESEARCH
    
    U. Bierfreund et al., "Recombinant GM2-activator protein stimulates in vivo degradation of GA2 inGM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay", NEUROCHEM R, 24(2), 1999, pp. 295-300
75. Cappello, S; Liu, NX; Musselli, C; Brezicka, FT; Livingston, PO; Ragupathi, G
    Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    S. Cappello et al., "Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells", CANCER IMMU, 48(9), 1999, pp. 483-492
76. Kolter, T; Doering, T; Wilkening, G; Werth, N; Sandhoff, K
    Recent advances in the biochemistry of glycosphingolipid metabolism
    BIOCHEMICAL SOCIETY TRANSACTIONS
    
    T. Kolter et al., "Recent advances in the biochemistry of glycosphingolipid metabolism", BIOCH SOC T, 27(4), 1999, pp. 409-415
77. Kim, SK; Ragupathi, G; Musselli, C; Choi, SJ; Park, YS; Livingston, PO
    Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines
    VACCINE
    
    S.K. Kim et al., "Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugatecancer vaccines", VACCINE, 18(7-8), 1999, pp. 597-603
78. Cavanna, B; Carpo, M; Pedotti, R; Scarpini, E; Meucci, N; Allaria, S; Scarlato, G; Nobile-Orazio, E
    Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line
    JOURNAL OF NEUROIMMUNOLOGY
    
    B. Cavanna et al., "Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line", J NEUROIMM, 94(1-2), 1999, pp. 157-164
79. Takiyama, Y; Sato, Y; Sawada, M; Nishizawa, M; Nakano, I; Kusunoki, S
    An unusual case of facial diplegia
    MUSCLE & NERVE
    
    Y. Takiyama et al., "An unusual case of facial diplegia", MUSCLE NERV, 22(6), 1999, pp. 778-779
80. Sonnino, S; Brocca, P; Acquotti, D; Bernardi, A; Raimondi, L; Kiso, M; Ishida, H; Li, SC; Li, YT
    The structural basis for the susceptibility of gangliosides to enzymatic degradation
    BIOSCIENCE REPORTS
    
    S. Sonnino et al., "The structural basis for the susceptibility of gangliosides to enzymatic degradation", BIOSCI REP, 19(3), 1999, pp. 163-168
81. Crawley, AC; Jones, MZ; Bonning, LE; Finnie, JW; Hopwood, JJ
    alpha-mannosidosis in the guinea pig: A new animal model for lysosomal storage disorders
    PEDIATRIC RESEARCH
    
    A.C. Crawley et al., "alpha-mannosidosis in the guinea pig: A new animal model for lysosomal storage disorders", PEDIAT RES, 46(5), 1999, pp. 501-509
82. Forster, A; Heuss, D; Claus, D
    Hexosaminidase deficiency is a differential diagnosis of spinocerebellar degeneration
    NERVENARZT
    
    A. Forster et al., "Hexosaminidase deficiency is a differential diagnosis of spinocerebellar degeneration", NERVENARZT, 70(2), 1999, pp. 162-166
83. Slovin, SF; Ragupathi, G; Adluri, S; Ungers, G; Terry, K; Kim, S; Spassova, M; Bornmann, WG; Fazzari, M; Dantis, L; Olkiewicz, K; Lloyd, KO; Livingston, PO; Danishefsky, SJ; Scher, HI
    Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globoH hexasaccharide conjugate in man
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    S.F. Slovin et al., "Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globoH hexasaccharide conjugate in man", P NAS US, 96(10), 1999, pp. 5710-5715
84. Saito, M; Ito, M; Sugiyama, K
    A specific loss of c-series gangliosides in pancreas streptozotocin-induced diabetic rats
    LIFE SCIENCES
    
    M. Saito et al., "A specific loss of c-series gangliosides in pancreas streptozotocin-induced diabetic rats", LIFE SCI, 64(20), 1999, pp. 1803-1810
85. Carpo, M; Pedotti, R; Allaria, S; Lolli, F; Mata, S; Cavaletti, G; Protti, A; Pomati, S; Scarlato, G; Nobile-Orazio, E
    Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies
    JOURNAL OF THE NEUROLOGICAL SCIENCES
    
    M. Carpo et al., "Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies", J NEUR SCI, 168(2), 1999, pp. 78-84
86. Khalili-Shirazi, A; Gregson, N; Gray, I; Rees, J; Winer, J; Hughes, R
    Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    A. Khalili-Shirazi et al., "Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection", J NE NE PSY, 66(3), 1999, pp. 376-379
87. Zervas, M; Walkley, SU
    Ferret pyramidal cell dendritogenesis: Changes in morphology and ganglioside expression during cortical development
    JOURNAL OF COMPARATIVE NEUROLOGY
    
    M. Zervas e S.U. Walkley, "Ferret pyramidal cell dendritogenesis: Changes in morphology and ganglioside expression during cortical development", J COMP NEUR, 413(3), 1999, pp. 429-448
88. Neufeld, EB; Wastney, M; Patel, S; Suresh, S; Cooney, AM; Dwyer, NK; Roff, CF; Ohno, K; Morris, JA; Carstea, ED; Incardona, JP; Strauss, JF; Vanier, MT; Patterson, MC; Brady, RO; Pentchev, PG; Blanchette-Mackie, EJ
    The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    E.B. Neufeld et al., "The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo", J BIOL CHEM, 274(14), 1999, pp. 9627-9635
89. Yamamoto, H; Iida-Tanaka, N; Kasama, T; Ishizuka, I; Kushi, Y; Handa, S
    Isolation and characterization of a novel Forssman active acidic glycosphingolipid with branched isoglobo-, ganglio-, and neolacto-series hybrid sugar chains
    JOURNAL OF BIOCHEMISTRY
    
    H. Yamamoto et al., "Isolation and characterization of a novel Forssman active acidic glycosphingolipid with branched isoglobo-, ganglio-, and neolacto-series hybrid sugar chains", J BIOCHEM, 125(5), 1999, pp. 923-930
90. Giehl, A; Lemm, T; Bartelsen, O; Sandhoff, K; Blume, A
    Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    A. Giehl et al., "Interaction of the GM2-activator protein with phospholipid-ganglioside bilayer membranes and with monolayers at the air-water interface", EUR J BIOCH, 261(3), 1999, pp. 650-658
91. Perez, LF; Ribeiro, HM; Casal, JA; Pinto, RA; Miranda, MCS; Tutor, JC
    Thermodynamic characterisation of the mutated isoenzyme A of beta-N-acetylhexosaminidase in GM2-gangliosidosis B1 variant
    CLINICA CHIMICA ACTA
    
    L.F. Perez et al., "Thermodynamic characterisation of the mutated isoenzyme A of beta-N-acetylhexosaminidase in GM2-gangliosidosis B1 variant", CLIN CHIM A, 285(1-2), 1999, pp. 45-51
92. Morton, DL; Ollila, DW; Hsueh, EC; Essner, R; Gupta, RK
    Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma
    CA-A CANCER JOURNAL FOR CLINICIANS
    
    D.L. Morton et al., "Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma", CA-A CANC J, 49(2), 1999, pp. 101
93. Falk, T; Garver, WS; Erickson, RP; Wilson, JM; Yool, AJ
    Expression of Niemann-Pick type C transcript in rodent cerebellum in vivo and in vitro
    BRAIN RESEARCH
    
    T. Falk et al., "Expression of Niemann-Pick type C transcript in rodent cerebellum in vivo and in vitro", BRAIN RES, 839(1), 1999, pp. 49-57
94. Li, YT; Li, SC
    Enzymatic hydrolysis of glycosphingolipids
    ANALYTICAL BIOCHEMISTRY
    
    Y.T. Li e S.C. Li, "Enzymatic hydrolysis of glycosphingolipids", ANALYT BIOC, 273(1), 1999, pp. 1-11
95. Chen, B; Rigat, B; Curry, C; Mahuran, DJ
    Structure of the GM2A gene: Identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    B. Chen et al., "Structure of the GM2A gene: Identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2", AM J HU GEN, 65(1), 1999, pp. 77-87
96. Fox, J; Li, YT; Dawson, G; Alleman, A; Johnsrude, J; Schumacher, J; Homer, B
    Naturally occurring G(M2) gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B G(M2) gangliosidosis)
    ACTA NEUROPATHOLOGICA
    
    J. Fox et al., "Naturally occurring G(M2) gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B G(M2) gangliosidosis)", ACT NEUROP, 97(1), 1999, pp. 57-62
97. OLLILA DW; KELLEY MC; GAMMON G; MORTON DL
    OVERVIEW OF MELANOMA VACCINES - ACTIVE SPECIFIC IMMUNOTHERAPY FOR MELANOMA PATIENTS
    Seminars in surgical oncology
    
    D.W. Ollila et al., "OVERVIEW OF MELANOMA VACCINES - ACTIVE SPECIFIC IMMUNOTHERAPY FOR MELANOMA PATIENTS", Seminars in surgical oncology, 14(4), 1998, pp. 328-336
98. Ozkara, HA; Navon, R
    At least six different mutations in HEXA gene cause Tay-Sachs disease among the Turkish population
    MOLECULAR GENETICS AND METABOLISM
    
    H.A. Ozkara e R. Navon, "At least six different mutations in HEXA gene cause Tay-Sachs disease among the Turkish population", MOL GEN MET, 65(3), 1998, pp. 250-253
99. FOON KA; SEN G; HUTCHINS L; KASHALA OL; BARAL R; BANERJEE M; CHAKRABORTY M; GARRISON J; REISFELD RA; BHATTACHARYACHATTERJEE M
    ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2
    Clinical cancer research
    
    K.A. Foon et al., "ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2", Clinical cancer research, 4(5), 1998, pp. 1117-1124
100. FOON KA; SEN G; HUTCHINS L; KASHALA OL; BARAL R; BANERJEE M; CHAKRABORTY M; GARRISON J; REISFELD RA; BHATTACHARYACHATTERJEE M
     ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2
     Clinical cancer research
     
     K.A. Foon et al., "ANTIBODY-RESPONSES IN MELANOMA PATIENTS IMMUNIZED WITH AN ANTIIDIOTYPE ANTIBODY MIMICKING DISIALOGANGLIOSIDE GD2", Clinical cancer research, 4(5), 1998, pp. 1117-1124